Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NVET

(NVET) (NVET) Stock Price, News & Analysis

(NVET) logo

About (NVET) Stock (NASDAQ:NVET)

Advanced Chart

Key Stats

Today's Range
$6.72
$6.72
50-Day Range
N/A
52-Week Range
$2.75
$6.76
Volume
N/A
Average Volume
38,104 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NVET Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (NVET) and its competitors with MarketBeat's FREE daily newsletter.

NVET Stock News Headlines

Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
See More Headlines

NVET Stock Analysis - Frequently Asked Questions

(NVET) (NASDAQ:NVET) announced its quarterly earnings results on Thursday, May, 11th. The biopharmaceutical company reported ($0.51) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.49) by $0.02.

(NVET) (NVET) raised $58 million in an IPO on Thursday, February 5th 2015. The company issued 4,000,000 shares at $13.00-$16.00 per share. BofA Merrill Lynch and Cowen and Company acted as the underwriters for the IPO and Piper Jaffray and JMP Securities were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that (NVET) investors own include Frontline (FRO), Achillion Pharmaceuticals (ACHN), Anthera Pharmaceuticals (ANTH), Sphere 3D (ANY), Arena Pharmaceuticals (ARNA), Yamana Gold (AUY) and BioLineRx (BLRX).

Company Calendar

Last Earnings
5/11/2017
Today
7/12/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:NVET
CIK
1618561
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:NVET) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners